Literature DB >> 22285308

Brain cancer mortality rates increase with Toxoplasma gondii seroprevalence in France.

Marion Vittecoq1, Eric Elguero, Kevin D Lafferty, Benjamin Roche, Jacques Brodeur, Michel Gauthier-Clerc, Dorothée Missé, Frédéric Thomas.   

Abstract

The incidence of adult brain cancer was previously shown to be higher in countries where the parasite Toxoplasma gondii is common, suggesting that this brain protozoan could potentially increase the risk of tumor formation. Using countries as replicates has, however, several potential confounding factors, particularly because detection rates vary with country wealth. Using an independent dataset entirely within France, we further establish the significance of the association between T. gondii and brain cancer and find additional demographic resolution. In adult age classes 55 years and older, regional mortality rates due to brain cancer correlated positively with the local seroprevalence of T. gondii. This effect was particularly strong for men. While this novel evidence of a significant statistical association between T. gondii infection and brain cancer does not demonstrate causation, these results suggest that investigations at the scale of the individual are merited.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22285308     DOI: 10.1016/j.meegid.2012.01.013

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  23 in total

1.  Determination of a Key Antigen for Immunological Intervention To Target the Latent Stage of Toxoplasma gondii.

Authors:  Qila Sa; Eri Ochiai; Ashish Tiwari; Jeremi Mullins; Nilabh Shastri; Corinne Mercier; Marie-France Cesbron-Delauw; Yasuhiro Suzuki
Journal:  J Immunol       Date:  2017-04-26       Impact factor: 5.422

Review 2.  The immune system utilizes two distinct effector mechanisms of T cells depending on two different life cycle stages of a single pathogen, Toxoplasma gondii, to control its cerebral infection.

Authors:  Yasuhiro Suzuki
Journal:  Parasitol Int       Date:  2019-11-25       Impact factor: 2.230

3.  CD8(+) T cells remove cysts of Toxoplasma gondii from the brain mostly by recognizing epitopes commonly expressed by or cross-reactive between type II and type III strains of the parasite.

Authors:  Eri Ochiai; Qila Sa; Sara Perkins; Michael E Grigg; Yasuhiro Suzuki
Journal:  Microbes Infect       Date:  2016-04-12       Impact factor: 2.700

Review 4.  Toxoplasma histone acetylation remodelers as novel drug targets.

Authors:  Laura Vanagas; Victoria Jeffers; Silvina S Bogado; Maria C Dalmasso; William J Sullivan; Sergio O Angel
Journal:  Expert Rev Anti Infect Ther       Date:  2012-10       Impact factor: 5.091

5.  The relationship between owning a cat and the risk of developing a brain cancer in a prospective study of UK women: comment on Thomas et al.

Authors:  V S Benson; J Green; V Beral
Journal:  Biol Lett       Date:  2012-08-22       Impact factor: 3.703

6.  Penetration of CD8+ Cytotoxic T Cells into Large Target, Tissue Cysts of Toxoplasma gondii, Leads to Its Elimination.

Authors:  Ashish Tiwari; Rancie Hannah; Jenny Lutshumba; Eri Ochiai; Louis M Weiss; Yasuhiro Suzuki
Journal:  Am J Pathol       Date:  2019-07-10       Impact factor: 4.307

Review 7.  A pathway to cure chronic infection with Toxoplasma gondii through immunological intervention.

Authors:  Yasuhiro Suzuki
Journal:  Parasitol Int       Date:  2020-12-01       Impact factor: 2.230

8.  Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders.

Authors:  C J Carter
Journal:  J Pathog       Date:  2013-03-04

9.  In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents.

Authors:  Maria L Alomar; Federico A O Rasse-Suriani; Agustina Ganuza; Verónica M Cóceres; Franco M Cabrerizo; Sergio O Angel
Journal:  BMC Res Notes       Date:  2013-05-10

10.  Applying ecological and evolutionary theory to cancer: a long and winding road.

Authors:  Frédéric Thomas; Daniel Fisher; Philippe Fort; Jean-Pierre Marie; Simon Daoust; Benjamin Roche; Christoph Grunau; Céline Cosseau; Guillaume Mitta; Stephen Baghdiguian; François Rousset; Patrice Lassus; Eric Assenat; Damien Grégoire; Dorothée Missé; Alexander Lorz; Frédérique Billy; William Vainchenker; François Delhommeau; Serge Koscielny; Raphael Itzykson; Ruoping Tang; Fanny Fava; Annabelle Ballesta; Thomas Lepoutre; Liliana Krasinska; Vjekoslav Dulic; Peggy Raynaud; Philippe Blache; Corinne Quittau-Prevostel; Emmanuel Vignal; Hélène Trauchessec; Benoit Perthame; Jean Clairambault; Vitali Volpert; Eric Solary; Urszula Hibner; Michael E Hochberg
Journal:  Evol Appl       Date:  2012-11-16       Impact factor: 5.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.